Nadja Kopp - Concepedia

Author

Nadja Kopp

Dana-Farber Cancer Institute

Also Known As

N Kopp, N. Kopp, Nadja Kopp, Una Vojinovic

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Ludwig-Maximilians-Universität München German Cancer Research Center

About

Nadja Kopp is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.1K
2	Immunology	3	3	752
3	Engineering	2	2	345
4	Cell Biology	2	2	422
5	Pathology	2	2	651

Nadja Kopp

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Alessandro Pastore, Vindi Jurinović, Robert Kridel, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyFollicular Lymphoma	2015	608
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane, Blood	2013	423
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia Christopher J. Ott, Nadja Kopp, Liat Bird, Blood	2012	367
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Cancer Cell Knockout MouseXenotransplantationXenografts Enables DiscoveryEngineeringIn Vivo System	2016	302
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition Oliver Weigert, Andrew A. Lane, Liat Bird, The Journal of Experimental Medicine	2012	161
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp, Cancer Cell Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematology	2015	120
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance Akinori Yoda, Guillaume Adelmant, Jérôme Tamburini, Nature Medicine	2014	100
Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation Oliver Weigert, Nadja Kopp, Andrew A. Lane, Cancer Discovery	2011	98
Changing pattern of primary hyperoxaluria in Switzerland Nadja Kopp, Ernst Leumann Nephrology Dialysis Transplantation	1995	93
BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death Chaitali Dutta, Tovah A. Day, Nadja Kopp, Cancer Research	2012	54

Page 1